默克制药：公司预计特朗普15%医药关税在2025年造成的“影响偏低”

Core Viewpoint - The company expects that the impact of the 15% pharmaceutical tariff proposed by President Trump in 2025 will be "relatively low" [2] Group 1 - The company is assessing the potential effects of the proposed tariff on its operations and financial performance [2] - The anticipated low impact suggests that the company may have strategies in place to mitigate the effects of such tariffs [2]